Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

Streamlining and translating basic science discoveries into the clinic

Streamlining and translating basic science discoveries into the clinic

Human leukemia virus increases disease risk by changing the way DNA loops inside our cells

Human leukemia virus increases disease risk by changing the way DNA loops inside our cells

Researchers show how mutant CALR protein triggers cancer

Researchers show how mutant CALR protein triggers cancer

DNA patterns in circulating blood cells can help identify spastic cerebral palsy

DNA patterns in circulating blood cells can help identify spastic cerebral palsy

Researchers diagnose cerebral palsy using AI and next-generation sequencing

Researchers diagnose cerebral palsy using AI and next-generation sequencing

UC Riverside researcher receives grants to advance cancer, ALS research

UC Riverside researcher receives grants to advance cancer, ALS research

Harnessing Pediatric Cancer Genomic Data in the Cloud

Harnessing Pediatric Cancer Genomic Data in the Cloud

Study tests accuracy of device designed to detect heart dysfunction in childhood cancer survivors

Study tests accuracy of device designed to detect heart dysfunction in childhood cancer survivors

New guidelines recommend newborns with Down’s syndrome to receive leukemia test

New guidelines recommend newborns with Down’s syndrome to receive leukemia test

OHSU Knight Cancer Institute Director wins 2018 Tang Prize in Biopharmaceutical Science

OHSU Knight Cancer Institute Director wins 2018 Tang Prize in Biopharmaceutical Science

Novel approach induces cell death via dual targeting of DNA repair mechanism

Novel approach induces cell death via dual targeting of DNA repair mechanism

Cureworks collaborative aims to accelerate development of immunotherapies for pediatric cancer

Cureworks collaborative aims to accelerate development of immunotherapies for pediatric cancer

Researchers identify racial differences in breast cancer immune microenvironment

Researchers identify racial differences in breast cancer immune microenvironment

Protein inhibitor drug found to be safe and effective in treating patients with acute myeloid leukemia

Protein inhibitor drug found to be safe and effective in treating patients with acute myeloid leukemia

Study finds increase in lifestyle-related cancers over the past decade

Study finds increase in lifestyle-related cancers over the past decade

Phase I trial shows safety of investigational drug in treating chronic lymphocytic leukemia

Phase I trial shows safety of investigational drug in treating chronic lymphocytic leukemia

MD Anderson and Amgen collaborate to accelerate early-stage oncology therapies

MD Anderson and Amgen collaborate to accelerate early-stage oncology therapies

Scientists engineer bi-specific antibodies that attract immune killers directly to cancer cells

Scientists engineer bi-specific antibodies that attract immune killers directly to cancer cells

FDA-approved drug for lymphoma and leukemia may help treat common type of brain tumor

FDA-approved drug for lymphoma and leukemia may help treat common type of brain tumor